Analysed RENOVORX INC (RNXT:NASDAQ) News Sources
RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter
14-05-2026
yahoo.com
RenovoRx Inc (RNXT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Expansion
15-05-2026
yahoo.com
RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th
19-05-2026
yahoo.com
RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting
26-05-2026
yahoo.com
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
28-05-2026
yahoo.com
RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd
04-06-2026
yahoo.com
What is the current price of RENOVORX INC (RNXT:NASDAQ)?
The current price of RENOVORX INC (RNXT:NASDAQ) is $0.8438.
RENOVORX INC (RNXT:NASDAQ) absolute price change since previous trading day?
The absolute price change of RENOVORX INC (RNXT:NASDAQ) since the previous trading day is $-0.0208.
RENOVORX INC (RNXT:NASDAQ) percentage price change since previous trading day?
The percentage price change of RENOVORX INC (RNXT:NASDAQ) since the previous trading day is -2.4057%.
What is the most recent average sentiment score for RENOVORX INC (RNXT:NASDAQ)?
The most recent average sentiment score for RENOVORX INC (RNXT:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for RENOVORX INC (RNXT:NASDAQ)?
The most recent sentiment for RENOVORX INC (RNXT:NASDAQ) is .
SEC-8K** Filing Available For RENOVORX INC (RNXT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.